Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.
ClinicalTrials.gov study NCT02867332. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.
Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
ClinicalTrials.gov study NCT03877250. IPD Sharing: YES. Countries: 1. Publications: 0.
Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer
ClinicalTrials.gov study NCT04984096. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
ClinicalTrials.gov study NCT07272382. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases
ClinicalTrials.gov study NCT06124729. IPD Sharing: NO. Countries: 0. Publications: 1.
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
ClinicalTrials.gov study NCT06031376. IPD Sharing: YES. Countries: 1. Publications: 0.
Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
ClinicalTrials.gov study NCT03514017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
ClinicalTrials.gov study NCT05034536. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
ClinicalTrials.gov study NCT04239443. IPD Sharing: YES. Countries: 1. Publications: 0.
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
ClinicalTrials.gov study NCT04193696. IPD Sharing: UNDECIDED. Countries: 0. Publications: 7.
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04214249. IPD Sharing: YES. Countries: 1. Publications: 0.
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
ClinicalTrials.gov study NCT03307759. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepato
ClinicalTrials.gov study NCT03071094. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
ClinicalTrials.gov study NCT02989714. IPD Sharing: NO. Countries: 1. Publications: 0.
Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
ClinicalTrials.gov study NCT03620019. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
ClinicalTrials.gov study NCT04115410. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04696055. IPD Sharing: NO. Countries: 8. Publications: 0.
Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
ClinicalTrials.gov study NCT05732493. IPD Sharing: NO. Countries: 0. Publications: 1.
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
ClinicalTrials.gov study NCT04767906. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Pro
ClinicalTrials.gov study NCT03321630. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.